FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292451707> ?p ?o ?g. }

• W4292451707 endingPage "4992" @default.
• W4292451707 startingPage "4992" @default.
• W4292451707 abstract "Auranamide and patriscabratine are amides from Melastoma malabathricum (L.) Smith. Their anti-inflammatory activity and nuclear factor erythroid 2-related factor 2 (NRF2) activation ability were evaluated using Escherichia coli lipopolysaccharide (LPSEc)-stimulated murine macrophages (RAW264.7) and murine hepatoma (Hepa-1c1c7) cells, respectively. The cytotoxicity of the compounds was assessed using a 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay. The anti-inflammatory activity was determined by measuring the nitric oxide (NO) production and pro-inflammatory cytokines (Interleukin (IL)-1β, Interferon (IFN)-γ, tumour necrosis factor (TNF)-α, and IL-6) and mediators (NF-κB and COX-2). NRF2 activation was determined by measuring the nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) quinone oxidoreductase 1 (NQO1), nuclear NRF2 and hemeoxygenase (HO)-1. In vitro metabolic stability was assessed using the mouse, rat, and human liver microsomes. The compounds were non-toxic to the cells at 10 μM. Both compounds showed dose-dependent effects in downregulating NO production and pro-inflammatory cytokines and mediators. The compounds also showed upregulation of NQO1 activity and nuclear NRF2 and HO-1 levels. The compounds were metabolically stable in mouse, rat and human liver microsomes. The possible molecular targets of NRF2 activation by these two compounds were predicted using molecular docking studies and it was found that the compounds might inhibit the Kelch domain of KEAP1 and GSK-3β activity. The physicochemical and drug-like properties of the test compounds were predicted using Schrodinger small molecule drug discovery suite (v.2022-2)." @default.
• W4292451707 created "2022-08-20" @default.
• W4292451707 creator A5014523412 @default.
• W4292451707 creator A5016594092 @default.
• W4292451707 creator A5022956567 @default.
• W4292451707 creator A5034511488 @default.
• W4292451707 creator A5040462221 @default.
• W4292451707 creator A5043225827 @default.
• W4292451707 creator A5053120398 @default.
• W4292451707 creator A5054445289 @default.
• W4292451707 creator A5060024728 @default.
• W4292451707 date "2022-08-05" @default.
• W4292451707 modified "2023-09-26" @default.
• W4292451707 title "Anti-Inflammatory Effects of Auranamide and Patriscabratine—Mechanisms and In Silico Studies" @default.
• W4292451707 cites W1493240590 @default.
• W4292451707 cites W1969418532 @default.
• W4292451707 cites W1994799019 @default.
• W4292451707 cites W1995801479 @default.
• W4292451707 cites W2002015567 @default.
• W4292451707 cites W2022582116 @default.
• W4292451707 cites W2025907706 @default.
• W4292451707 cites W2026361319 @default.
• W4292451707 cites W2028155609 @default.
• W4292451707 cites W2035676834 @default.
• W4292451707 cites W2059882356 @default.
• W4292451707 cites W2077984371 @default.
• W4292451707 cites W2099852670 @default.
• W4292451707 cites W2127929684 @default.
• W4292451707 cites W2589064393 @default.
• W4292451707 cites W2773072411 @default.
• W4292451707 cites W2776142915 @default.
• W4292451707 cites W2790542561 @default.
• W4292451707 cites W2801318738 @default.
• W4292451707 cites W2891794739 @default.
• W4292451707 cites W2904863597 @default.
• W4292451707 cites W2907855283 @default.
• W4292451707 cites W3015784228 @default.
• W4292451707 cites W3109325464 @default.
• W4292451707 cites W3109778971 @default.
• W4292451707 cites W3113898098 @default.
• W4292451707 cites W3211798705 @default.
• W4292451707 cites W4214662449 @default.
• W4292451707 cites W4214685870 @default.
• W4292451707 cites W4221060738 @default.
• W4292451707 cites W4226072884 @default.
• W4292451707 cites W4285009130 @default.
• W4292451707 doi "https://doi.org/10.3390/molecules27154992" @default.
• W4292451707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35956947" @default.
• W4292451707 hasPublicationYear "2022" @default.
• W4292451707 type Work @default.
• W4292451707 citedByCount "2" @default.
• W4292451707 countsByYear W42924517072022 @default.
• W4292451707 countsByYear W42924517072023 @default.
• W4292451707 crossrefType "journal-article" @default.
• W4292451707 hasAuthorship W4292451707A5014523412 @default.
• W4292451707 hasAuthorship W4292451707A5016594092 @default.
• W4292451707 hasAuthorship W4292451707A5022956567 @default.
• W4292451707 hasAuthorship W4292451707A5034511488 @default.
• W4292451707 hasAuthorship W4292451707A5040462221 @default.
• W4292451707 hasAuthorship W4292451707A5043225827 @default.
• W4292451707 hasAuthorship W4292451707A5053120398 @default.
• W4292451707 hasAuthorship W4292451707A5054445289 @default.
• W4292451707 hasAuthorship W4292451707A5060024728 @default.
• W4292451707 hasBestOaLocation W42924517071 @default.
• W4292451707 hasConcept C109316439 @default.
• W4292451707 hasConcept C178790620 @default.
• W4292451707 hasConcept C17991360 @default.
• W4292451707 hasConcept C181199279 @default.
• W4292451707 hasConcept C185592680 @default.
• W4292451707 hasConcept C202751555 @default.
• W4292451707 hasConcept C203014093 @default.
• W4292451707 hasConcept C2777622882 @default.
• W4292451707 hasConcept C2777989768 @default.
• W4292451707 hasConcept C2778754761 @default.
• W4292451707 hasConcept C38485361 @default.
• W4292451707 hasConcept C519581460 @default.
• W4292451707 hasConcept C55493867 @default.
• W4292451707 hasConcept C86803240 @default.
• W4292451707 hasConcept C87644729 @default.
• W4292451707 hasConcept C98274493 @default.
• W4292451707 hasConceptScore W4292451707C109316439 @default.
• W4292451707 hasConceptScore W4292451707C178790620 @default.
• W4292451707 hasConceptScore W4292451707C17991360 @default.
• W4292451707 hasConceptScore W4292451707C181199279 @default.
• W4292451707 hasConceptScore W4292451707C185592680 @default.
• W4292451707 hasConceptScore W4292451707C202751555 @default.
• W4292451707 hasConceptScore W4292451707C203014093 @default.
• W4292451707 hasConceptScore W4292451707C2777622882 @default.
• W4292451707 hasConceptScore W4292451707C2777989768 @default.
• W4292451707 hasConceptScore W4292451707C2778754761 @default.
• W4292451707 hasConceptScore W4292451707C38485361 @default.
• W4292451707 hasConceptScore W4292451707C519581460 @default.
• W4292451707 hasConceptScore W4292451707C55493867 @default.
• W4292451707 hasConceptScore W4292451707C86803240 @default.
• W4292451707 hasConceptScore W4292451707C87644729 @default.
• W4292451707 hasConceptScore W4292451707C98274493 @default.
• W4292451707 hasFunder F4320321709 @default.
• W4292451707 hasFunder F4320325726 @default.

• next